Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning
Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol. Oral dosage form comprises an opioid and a dosing structure that provides extended release of...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | nor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SATHYAN GAYATRI DAVAR NIPUN HASTEDT JAYNE PORS LINDA HEARNEY CASADEVALL GEMMA |
description | Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol.
Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO20064997LL</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO20064997LL</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO20064997LL3</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeodxgMIRUXpWiwuim7cl8H8tsEkU5K0eHzT4gHczIf_3p9l9ik9bMuuDZYjqBFPHmoI8Nq1xCOxeUsnRru5jKQkYIhRrJ2EyZdei1Yg8Www82kbErLwZKHIpP8je538dPToEl9ni4ZNwOaXq2xbXp-X2w691Ag9v-AQ6_tjn-enY1Gcq-rwj_MF0O9IjQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><source>esp@cenet</source><creator>SATHYAN GAYATRI ; DAVAR NIPUN ; HASTEDT JAYNE ; PORS LINDA HEARNEY ; CASADEVALL GEMMA</creator><creatorcontrib>SATHYAN GAYATRI ; DAVAR NIPUN ; HASTEDT JAYNE ; PORS LINDA HEARNEY ; CASADEVALL GEMMA</creatorcontrib><description>Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol.
Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.</description><language>nor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070502&DB=EPODOC&CC=NO&NR=20064997L$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070502&DB=EPODOC&CC=NO&NR=20064997L$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SATHYAN GAYATRI</creatorcontrib><creatorcontrib>DAVAR NIPUN</creatorcontrib><creatorcontrib>HASTEDT JAYNE</creatorcontrib><creatorcontrib>PORS LINDA HEARNEY</creatorcontrib><creatorcontrib>CASADEVALL GEMMA</creatorcontrib><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><description>Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol.
Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeodxgMIRUXpWiwuim7cl8H8tsEkU5K0eHzT4gHczIf_3p9l9ik9bMuuDZYjqBFPHmoI8Nq1xCOxeUsnRru5jKQkYIhRrJ2EyZdei1Yg8Www82kbErLwZKHIpP8je538dPToEl9ni4ZNwOaXq2xbXp-X2w691Ag9v-AQ6_tjn-enY1Gcq-rwj_MF0O9IjQ</recordid><startdate>20070502</startdate><enddate>20070502</enddate><creator>SATHYAN GAYATRI</creator><creator>DAVAR NIPUN</creator><creator>HASTEDT JAYNE</creator><creator>PORS LINDA HEARNEY</creator><creator>CASADEVALL GEMMA</creator><scope>EVB</scope></search><sort><creationdate>20070502</creationdate><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><author>SATHYAN GAYATRI ; DAVAR NIPUN ; HASTEDT JAYNE ; PORS LINDA HEARNEY ; CASADEVALL GEMMA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO20064997LL3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SATHYAN GAYATRI</creatorcontrib><creatorcontrib>DAVAR NIPUN</creatorcontrib><creatorcontrib>HASTEDT JAYNE</creatorcontrib><creatorcontrib>PORS LINDA HEARNEY</creatorcontrib><creatorcontrib>CASADEVALL GEMMA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SATHYAN GAYATRI</au><au>DAVAR NIPUN</au><au>HASTEDT JAYNE</au><au>PORS LINDA HEARNEY</au><au>CASADEVALL GEMMA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><date>2007-05-02</date><risdate>2007</risdate><abstract>Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol.
Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | nor |
recordid | cdi_epo_espacenet_NO20064997LL |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A57%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SATHYAN%20GAYATRI&rft.date=2007-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO20064997LL%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |